خط مشی دسترسیدرباره ماپشتیبانی آنلاین
ثبت نامثبت نام
راهنماراهنما
فارسی
ورودورود
صفحه اصلیصفحه اصلی
جستجوی مدارک
تمام متن
منابع دیجیتالی
رکورد قبلیرکورد بعدی
Information of biblio record :BL
Language of Text,Soundtrack etc.:English
Record identifier:2043
Title and statement of responsibility and:Evaluating pharmaceuticals for health policy and reimbursement /\ edited by Nick Freemantle and Suzanne Hill.
Publication:Malden, Mass. :: BMJ Books/Blackwell Pub.,, 2004.
Physical Description:ix, 268 p. ::ill. ;;22 cm.
Internal Bibliographies/Indexes:Includes bibliographical references and index.
Contents Note:Development of marketing authorisation procedures for pharmaceuticals / Alar Irs, Truus Janse de Hoog, Lembit R�ago -- Interpreting clinical evidence / Nick Freemantle ... [et al.] -- International pharmaceutical policy: health creation or wealth creation? / Karen Bloor, Alan Maynard -- Development of fourth hurdle policies around the world / Rod S. Taylor ... [et al.] -- Economic modelling in drug reimbursement / Glenn Salkeld, Nick Freemantle, Bernie O'Brien -- Priority setting in health care: matching decision criteria with policy objectives / Gina Brinsmead, Alan Williams -- Tensions in licensing and reimbursement decisions: the case of riluzole for amyotrophic lateral sclerosis / Stirling Bryan ... [et al.] --
Relationships between stakeholders: managing the war of words / Suzanne Hill, Kees de Joncheere -- Medicine and the media: good information or misleading hype? / Ray Moynihan, Lisa M. Schwartz, Steven Woloshin -- How to promote quality use of cost-effective medicines / Hans Hogerzeil, Kathleen Holloway -- Using economic evaluation to inform health policy and reimbursement: making it happen and making it sustainable / Andrew Mitchell -- Pricing of pharmaceuticals / David Newby, Andrew Creese, Alan Stevens -- Evaluating pharmaceuticals for health policy in low and middle income country settings / Andrew Creese ... [et al.].
International Standard Book Number (ISBN):0727917846 (pbk. : alk. paper)
Topical Name Used as Subject:Pharmaceutical policy.
Topical Name Used as Subject:Drug Evaluation-- Methods.
Topical Name Used as Subject:Pharmaceutical services insurance-- Economics.
Topical Name Used as Subject:Cost-Benefit Analysis.
Topical Name Used as Subject:Drug Costs.
Topical Name Used as Subject:Health Policy-- Economics.
Topical Name Used as Subject:Insurance, Health, Reimbursement-- Economics.
Personal Name - Alternative Intelectual Responsibility:Freemantle, Nick.
Hill, Suzanne.
LCC:‭RA401.A1‬‭E94 2004‬
Dewey Decimal Classification:
Other Class Numbers:
‭‭